Home/Filings/4/0001683168-23-009152
4//SEC Filing

DVONCH JEROME J 4

Accession 0001683168-23-009152

CIK 0001367083other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 5:24 PM ET

Size

5.6 KB

Accession

0001683168-23-009152

Insider Transaction Report

Form 4
Period: 2023-12-29
DVONCH JEROME J
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2023-12-29+60,000117,777 total
    Exercise: $0.18Exp: 2033-12-29Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control.
  • [F2]The options were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual grant of stock options.

Documents

1 file

Issuer

Sonoma Pharmaceuticals, Inc.

CIK 0001367083

Entity typeother

Related Parties

1
  • filerCIK 0001518735

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:24 PM ET
Size
5.6 KB